Bank of Montreal
LABD icon

Bank of Montreal’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bank of Montreal’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed -$86K – 4326
2015
Q3 		$86K Buy
+1
New +$70.8K ﹤0.01% 2697

Other funds holding LABD

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Bank of Montreal's LABD Position: Q4 2015 in Review

Bank of Montreal sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2015, closing a stake of 1 share — an estimated $86K sold.

Bank of Montreal first reported a position in LABD in Q3 2015 and held it in 1 quarter. The position peaked at $86K in Q3 2015. 6 funds tracked by Wall St. Rank hold LABD as of Q4 2015.

  • Bank of Montreal reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2015 after selling out during the quarter.
  • Bank of Montreal sold 1 Direxion Daily S&P Biotech Bear 3X ETF share in Q4 2015, an estimated $86K.
  • Bank of Montreal first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2015 and held it in 1 quarter.
  • Bank of Montreal's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $86K in Q3 2015.
  • 6 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2015.

Based on Bank of Montreal's 13F filing for Q4 2015, filed 9 Feb 2016.